Chapter/Section Purchase

1 Artificial Heart Lung Machines Market Overview
1.1 Product Overview and Scope of Artificial Heart Lung Machines
1.2 Artificial Heart Lung Machines Segment by Type
1.2.1 Global Artificial Heart Lung Machines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Artificial Heart Lung Machines Segment by Application
1.3.1 Global Artificial Heart Lung Machines Sales Comparison by Application: (2021-2027)
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Heart Lung Machines Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart Lung Machines Revenue 2016-2027
1.4.2 Global Artificial Heart Lung Machines Sales 2016-2027
1.4.3 Artificial Heart Lung Machines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Heart Lung Machines Market Competition by Manufacturers
2.1 Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Heart Lung Machines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Heart Lung Machines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Heart Lung Machines Manufacturing Sites, Area Served, Product Type
2.5 Artificial Heart Lung Machines Market Competitive Situation and Trends
2.5.1 Artificial Heart Lung Machines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Heart Lung Machines Players Market Share by Revenue
2.5.3 Global Artificial Heart Lung Machines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Heart Lung Machines Retrospective Market Scenario by Region
3.1 Global Artificial Heart Lung Machines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Artificial Heart Lung Machines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Artificial Heart Lung Machines Market Facts & Figures by Country
3.3.1 North America Artificial Heart Lung Machines Sales by Country
3.3.2 North America Artificial Heart Lung Machines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Heart Lung Machines Market Facts & Figures by Country
3.4.1 Europe Artificial Heart Lung Machines Sales by Country
3.4.2 Europe Artificial Heart Lung Machines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Heart Lung Machines Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Heart Lung Machines Sales by Region
3.5.2 Asia Pacific Artificial Heart Lung Machines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Artificial Heart Lung Machines Market Facts & Figures by Country
3.6.1 Latin America Artificial Heart Lung Machines Sales by Country
3.6.2 Latin America Artificial Heart Lung Machines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Heart Lung Machines Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Heart Lung Machines Sales by Country
3.7.2 Middle East and Africa Artificial Heart Lung Machines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Artificial Heart Lung Machines Historic Market Analysis by Type
4.1 Global Artificial Heart Lung Machines Sales Market Share by Type (2016-2021)
4.2 Global Artificial Heart Lung Machines Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Heart Lung Machines Price by Type (2016-2021)

5 Global Artificial Heart Lung Machines Historic Market Analysis by Application
5.1 Global Artificial Heart Lung Machines Sales Market Share by Application (2016-2021)
5.2 Global Artificial Heart Lung Machines Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Heart Lung Machines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 LivaNova (Sorin)
6.1.1 LivaNova (Sorin) Corporation Information
6.1.2 LivaNova (Sorin) Description and Business Overview
6.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
6.1.5 LivaNova (Sorin) Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Corporation Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo CV Group
6.4.1 Terumo CV Group Corporation Information
6.4.2 Terumo CV Group Description and Business Overview
6.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
6.4.5 Terumo CV Group Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Corporation Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 Tianjin Medical
6.6.1 Tianjin Medical Corporation Information
6.6.2 Tianjin Medical Description and Business Overview
6.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
6.6.5 Tianjin Medical Recent Developments/Updates

7 Artificial Heart Lung Machines Manufacturing Cost Analysis
7.1 Artificial Heart Lung Machines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Heart Lung Machines
7.4 Artificial Heart Lung Machines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Heart Lung Machines Distributors List
8.3 Artificial Heart Lung Machines Customers

9 Artificial Heart Lung Machines Market Dynamics
9.1 Artificial Heart Lung Machines Industry Trends
9.2 Artificial Heart Lung Machines Growth Drivers
9.3 Artificial Heart Lung Machines Market Challenges
9.4 Artificial Heart Lung Machines Market Restraints

10 Global Market Forecast
10.1 Artificial Heart Lung Machines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Heart Lung Machines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Artificial Heart Lung Machines by Type (2022-2027)
10.2 Artificial Heart Lung Machines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Heart Lung Machines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Artificial Heart Lung Machines by Application (2022-2027)
10.3 Artificial Heart Lung Machines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Heart Lung Machines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Artificial Heart Lung Machines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer